Mechanisms underlying neurocognitive dysfunctions in recurrent major depression.

Piotr Gałecki, Monika Talarowska, George Anderson, Michael Berk, Michael Maes
Author Information
  1. Piotr Gałecki: Department of Adult Psychiatry, Medical University of Łódź, Łódź, Poland.
  2. Monika Talarowska: Department of Adult Psychiatry, Medical University of Łódź, Łódź, Poland.
  3. George Anderson: CRC Scotland & London, London, United Kingdom.
  4. Michael Berk: Orygen Research Centre, Parkville, VIC, Australia.
  5. Michael Maes: IMPACT Strategic Research Centre, Deakin University, Geelong, VIC, Australia.

Abstract

Recent work shows that depression is intimately associated with changes in cognitive functioning, including memory, attention, verbal fluency, and other aspects of higher-order cognitive processing. Changes in cognitive functioning are more likely to occur when depressive episodes are recurrent and to abate to some degree during periods of remission. However, with accumulating frequency and duration of depressive episodes, cognitive deficits can become enduring, being evident even when mood improves. Such changes in cognitive functioning give depression links to mild cognitive impairment and thereby with neurodegenerative conditions, including Alzheimer's disease, Parkinson's disease, schizophrenia, and multiple sclerosis. Depression may then be conceptualized on a dimension of depression - mild cognitive impairment - dementia. The biological underpinnings of depression have substantial overlaps with those of neurodegenerative conditions, including reduced neurogenesis, increased apoptosis, reactive oxygen species, tryptophan catabolites, autoimmunity, and immune-inflammatory processes, as well as decreased antioxidant defenses. These evolving changes over the course of depressive episodes drive the association of depression with neurodegenerative conditions. As such, the changes in cognitive functioning in depression have important consequences for the treatment of depression and in reconceptualizing the role of depression in wider neuroprogressive conditions. Here we review the data on changes in cognitive functioning in recurrent major depression and their association with other central conditions.

References

  1. Am J Psychiatry. 1999 May;156(5):675-82 [PMID: 10327898]
  2. Bipolar Disord. 2001 Apr;3(2):88-94 [PMID: 11333068]
  3. Psychiatry Res. 2001 Sep 20;103(2-3):237-47 [PMID: 11549411]
  4. Am J Med Genet. 2002 Jan 8;114(1):74-8 [PMID: 11840509]
  5. J Neurol Neurosurg Psychiatry. 2002 Mar;72(3):400-2 [PMID: 11861707]
  6. Hippocampus. 2002;12(2):245-57 [PMID: 12000121]
  7. Pharmacol Biochem Behav. 2002 Aug;73(1):247-58 [PMID: 12076743]
  8. Neuropsychobiology. 2003;47(1):21-6 [PMID: 12606841]
  9. J Neurol. 2003 Apr;250(4):449-55 [PMID: 12700911]
  10. Psychol Med. 2003 May;33(4):739-45 [PMID: 12785476]
  11. J Neurol Neurosurg Psychiatry. 2004 Jan;75(1):126-9 [PMID: 14707321]
  12. Am J Psychiatry. 2004 Feb;161(2):262-70 [PMID: 14754775]
  13. Am J Psychiatry. 2004 Feb;161(2):286-93 [PMID: 14754778]
  14. Br J Clin Psychol. 2004 Jun;43(Pt 2):129-142 [PMID: 15169614]
  15. Arch Neurol. 2004 Aug;61(8):1290-3 [PMID: 15313849]
  16. BMJ. 2004 Oct 16;329(7471):881 [PMID: 15345599]
  17. J Psychiatr Res. 2004 Nov-Dec;38(6):567-76 [PMID: 15458852]
  18. J Psychiatr Res. 2005 Mar;39(2):129-35 [PMID: 15589560]
  19. Curr Biol. 2005 Mar 8;15(5):424-9 [PMID: 15753036]
  20. Eur Arch Psychiatry Clin Neurosci. 2005 Dec;255(6):373-80 [PMID: 15793669]
  21. Brain Res. 2005 Jun 7;1046(1-2):187-94 [PMID: 15882843]
  22. Neuroimage. 2005 Jul 1;26(3):860-9 [PMID: 15955496]
  23. Biol Psychiatry. 2005 Aug 1;58(3):204-10 [PMID: 16018984]
  24. Neuron. 2005 Sep 15;47(6):907-18 [PMID: 16157284]
  25. Acta Psychiatr Scand. 2005 Dec;112(6):434-41 [PMID: 16279872]
  26. Lancet. 2006 Jan 14;367(9505):153-67 [PMID: 16413879]
  27. Dement Geriatr Cogn Disord. 2006;21(4):251-9 [PMID: 16465053]
  28. Postepy Hig Med Dosw (Online). 2006;60:209-16 [PMID: 16641890]
  29. J Neuropsychiatry Clin Neurosci. 2006 Spring;18(2):217-25 [PMID: 16720799]
  30. J Affect Disord. 2006 Nov;96(1-2):107-10 [PMID: 16782205]
  31. Psychiatr Pol. 2006 May-Jun;40(3):431-44 [PMID: 17037810]
  32. Kans Nurse. 2006 Oct;81(9):4-6 [PMID: 17111644]
  33. J Gerontol A Biol Sci Med Sci. 2006 Dec;61(12):1319-23 [PMID: 17234828]
  34. Hum Psychopharmacol. 2007 Mar;22(2):67-73 [PMID: 17299810]
  35. Acta Biochim Pol. 2007;54(1):1-9 [PMID: 17351668]
  36. Am J Geriatr Psychiatry. 2007 Jul;15(7):594-603 [PMID: 17353296]
  37. Acta Psychiatr Scand. 2007 Jun;115(6):458-65 [PMID: 17498157]
  38. Biol Psychiatry. 2007 Dec 1;62(11):1272-80 [PMID: 17585888]
  39. Pharmacol Ther. 2007 Oct;116(1):125-39 [PMID: 17597217]
  40. Psychol Med. 2007 Dec;37(12):1693-702 [PMID: 17610767]
  41. BMC Psychiatry. 2007 Jul 17;7:32 [PMID: 17634111]
  42. Biol Psychiatry. 2008 Feb 15;63(4):385-90 [PMID: 17640621]
  43. Neurochem Res. 2007 Oct;32(10):1749-56 [PMID: 17705097]
  44. Ann N Y Acad Sci. 2007 Dec;1121:499-527 [PMID: 17872395]
  45. J Pineal Res. 2007 Nov;43(4):365-71 [PMID: 17910605]
  46. Proc Natl Acad Sci U S A. 2008 Jan 8;105(1):329-34 [PMID: 18162554]
  47. Bipolar Disord. 2008 Feb;10(1):1-37 [PMID: 18199239]
  48. J Abnorm Psychol. 2008 Feb;117(1):182-92 [PMID: 18266496]
  49. Nat Rev Neurosci. 2008 Mar;9(3):182-94 [PMID: 18270514]
  50. Biol Psychiatry. 2008 Sep 15;64(6):484-90 [PMID: 18514163]
  51. J Int Neuropsychol Soc. 2008 Jul;14(4):552-61 [PMID: 18577284]
  52. Hum Psychopharmacol. 2008 Oct;23(7):571-85 [PMID: 18680211]
  53. J Int Neuropsychol Soc. 2009 Mar;15(2):196-204 [PMID: 19203431]
  54. Proc Natl Acad Sci U S A. 2009 Apr 14;106(15):6273-8 [PMID: 19329490]
  55. Psychol Med. 2010 Jan;40(1):29-39 [PMID: 19413917]
  56. Mitochondrion. 2009 Jun;9(3):186-95 [PMID: 19460297]
  57. Neuroscience. 2009 Sep 15;162(4):1429-36 [PMID: 19460420]
  58. Arch Gen Psychiatry. 2009 Jun;66(6):617-26 [PMID: 19487626]
  59. Psychiatry Clin Neurosci. 2009 Jun;63(3):423-5 [PMID: 19566776]
  60. Psychiatr Pol. 2009 Jan-Feb;43(1):31-40 [PMID: 19694398]
  61. Neurosci Lett. 2010 Jan 18;469(1):6-10 [PMID: 19914330]
  62. Pneumonol Alergol Pol. 2009;77(6):554-9 [PMID: 20013707]
  63. Am J Geriatr Psychiatry. 2010 Feb;18(2):98-116 [PMID: 20104067]
  64. Am J Geriatr Psychiatry. 2010 Mar;18(3):204-11 [PMID: 20224517]
  65. Psychiatry Res. 2010 Sep 30;183(3):202-8 [PMID: 20685091]
  66. Can J Psychiatry. 2010 Oct;55(10):669-76 [PMID: 20964946]
  67. Curr Med Chem. 2011;18(2):245-55 [PMID: 21110802]
  68. Eur J Neurol. 2011 May;18(5):680-5 [PMID: 21118329]
  69. Adv Med Sci. 2010;55(2):317-27 [PMID: 21163755]
  70. Dev Psychopathol. 2011 Feb;23(1):115-29 [PMID: 21262043]
  71. Int J Geriatr Psychiatry. 2011 Nov;26(11):1109-18 [PMID: 21370276]
  72. Biol Res Nurs. 2012 Apr;14(2):133-8 [PMID: 21586493]
  73. Fundam Clin Pharmacol. 2013 Apr;27(2):146-51 [PMID: 21790778]
  74. PLoS One. 2011;6(7):e22632 [PMID: 21799922]
  75. J Nerv Ment Dis. 2011 Sep;199(9):696-702 [PMID: 21878785]
  76. J Nutr Health Aging. 2011 Aug;15(8):695-8 [PMID: 21968867]
  77. Sleep. 2011 Dec 01;34(12):1699-706 [PMID: 22131608]
  78. Mol Biol Rep. 2012 May;39(5):5359-66 [PMID: 22170602]
  79. Clinics (Sao Paulo). 2011;66(9):1553-7 [PMID: 22179158]
  80. J Pineal Res. 2012 May;52(4):397-402 [PMID: 22225631]
  81. BMJ Open. 2012 Jan 11;2(1):e000647 [PMID: 22240653]
  82. Neurosci Lett. 2012 Feb 29;510(2):127-31 [PMID: 22273980]
  83. Psychiatr Pol. 2011 Nov-Dec;45(6):901-10 [PMID: 22335132]
  84. Adv Cogn Psychol. 2012;8(1):38-49 [PMID: 22419965]
  85. Neuromolecular Med. 2012 Sep;14(3):194-204 [PMID: 22552887]
  86. Neurochem Res. 2012 Aug;37(8):1761-7 [PMID: 22562440]
  87. J Neuroinflammation. 2012 May 29;9:101 [PMID: 22642744]
  88. BMC Med. 2012 Jun 29;10:66 [PMID: 22747645]
  89. Acta Psychiatr Scand. 2013 May;127(5):344-54 [PMID: 22900942]
  90. Neurosci Lett. 2012 Nov 14;530(1):53-8 [PMID: 23043890]
  91. Med Sci Monit. 2012 Dec;18(12):CR706-11 [PMID: 23197231]
  92. PLoS One. 2012;7(12):e52010 [PMID: 23284853]
  93. Chin Med J (Engl). 2013 Mar;126(6):1144-9 [PMID: 23506595]
  94. Brain Res. 2013 Aug 21;1527:174-88 [PMID: 23831520]
  95. Psychiatr Pol. 2013 Mar-Apr;47(2):255-67 [PMID: 23888759]
  96. BMC Psychiatry. 2013 Aug 02;13:203 [PMID: 23914931]
  97. Int J Geriatr Psychiatry. 2014 Apr;29(4):428-36 [PMID: 24022882]
  98. CNS Neurol Disord Drug Targets. 2014 Feb;13(1):126-36 [PMID: 24040808]
  99. Mol Neurobiol. 2014 Apr;49(2):771-83 [PMID: 24085563]
  100. Curr Pharm Des. 2014;20(23):3812-47 [PMID: 24180395]
  101. Sci Rep. 2013 Dec 02;3:3398 [PMID: 24292328]
  102. J Clin Psychiatry. 2014 Jan;75(1):8-14 [PMID: 24345473]
  103. Front Biosci (Landmark Ed). 2014 Jan 01;19:429-46 [PMID: 24389194]
  104. Sleep. 2014 Feb 01;37(2):351-8 [PMID: 24497663]
  105. Neuro Endocrinol Lett. 2013;34(8):780-6 [PMID: 24522026]
  106. Pharmacol Rep. 2013;65(6):1647-54 [PMID: 24553013]
  107. J Clin Child Adolesc Psychol. 2015;44(4):559-65 [PMID: 24731145]
  108. J Am Acad Child Adolesc Psychiatry. 2014 May;53(5):559-68.e6 [PMID: 24745955]
  109. J Affect Disord. 2014 Jun;161:144-9 [PMID: 24751322]
  110. Mol Neurobiol. 2014 Dec;50(3):1059-84 [PMID: 24752591]
  111. Neurobiol Dis. 2014 Aug;68:57-65 [PMID: 24769004]
  112. Med Sci Monit. 2014 Jun 02;20:905-12 [PMID: 24881886]
  113. CNS Neurol Disord Drug Targets. 2014;13(5):817-27 [PMID: 25012620]
  114. Mult Scler Relat Disord. 2015 Mar;4(2):112-23 [PMID: 25787187]
  115. Acta Neuropsychiatr. 2010 Oct;22(5):218-22 [PMID: 26952831]
  116. Acta Neuropsychiatr. 2003 Dec;15(6):368-80 [PMID: 26983772]
  117. Acta Neuropsychiatr. 2006 Oct;18(5):193-209 [PMID: 26989919]
  118. Methods Enzymol. 1987;142:590-6 [PMID: 3298987]
  119. Psychoneuroendocrinology. 1983;8(1):75-80 [PMID: 6308700]
  120. Am J Psychiatry. 1996 Apr;153(4):490-6 [PMID: 8599396]

MeSH Term

Apoptosis
Attention
Circadian Rhythm
Depressive Disorder, Major
Executive Function
Humans
Hypothalamo-Hypophyseal System
Inflammation
Memory
Neurocognitive Disorders
Neurogenesis
Oxidative Stress
Pituitary-Adrenal System
Psychomotor Performance
Reactive Oxygen Species
Tryptophan

Chemicals

Reactive Oxygen Species
Tryptophan

Word Cloud

Created with Highcharts 10.0.0depressioncognitivechangesfunctioningconditionsincludingdepressiveepisodesrecurrentneurodegenerativemildimpairmentdisease-associationmajorRecentworkshowsintimatelyassociatedmemoryattentionverbalfluencyaspectshigher-orderprocessingChangeslikelyoccurabatedegreeperiodsremissionHoweveraccumulatingfrequencydurationdeficitscanbecomeenduringevidentevenmoodimprovesgivelinkstherebyAlzheimer'sParkinson'sschizophreniamultiplesclerosisDepressionmayconceptualizeddimensiondementiabiologicalunderpinningssubstantialoverlapsreducedneurogenesisincreasedapoptosisreactiveoxygenspeciestryptophancatabolitesautoimmunityimmune-inflammatoryprocesseswelldecreasedantioxidantdefensesevolvingcoursedriveimportantconsequencestreatmentreconceptualizingrolewiderneuroprogressivereviewdatacentralMechanismsunderlyingneurocognitivedysfunctions

Similar Articles

Cited By